About this trial
The aim of this prospective cohort study was to investigate the effect of the time spent with relatives of patients treated in a tertiary intensive care unit on patient outcomes.
The main question it aimed to answer was:
Does spending more time with relatives of patients in intensive care result in lower sedative agent requirements? Does spending more time with relatives of patients in intensive care result in less delirium, fewer ventilator days, and shorter ICU stays?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18 and over.
Patients with at least one family member actively involved in the care process in the ICU.
Disqualifiers
Patients with pre-existing cognitive impairment or dementia.
Patients with severe traumatic brain injury.
Patients with an expected mortality in the ICU of more than 80%.
Absence of family members for patients admitted to the ICU.
Trial population
patients in a tertiary intensive care unit of a university hospital
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Sedative dose
It is the average daily dose of sedative drugs used by a patient. It will be calculated for each sedative drug. It will be calculated by dividing all doses taken by the number of days of hospitalization.
Secondary outcomes
Delirium
Each patient will be assessed for delirium every day during their hospitalization. CAM-ICU scoring will be used for assessment. The average number of delirium days for each patient will be found by dividing the number of days they were in delirium by the total number of days they were in hospital.
Ventilatory days
For each patient, the number of days they are on a ventilator will be calculated as a percentage of their length of stay. For each patient, the days they receive invasive ventilation will be divided by the number of days they are treated in the intensive care unit to calculate the percentage.
Stay in intensive care unit
The length of time each patient stays in intensive care will be recorded.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.